Washed Microbiota Transplantation for Malnutrition
Condition(s) studied
Investigational drug(s) / intervention(s)
washed microbiota transplantation: The prepared microbiota suspension was infused into the patients' gut.
Study summary
Malnutrition is a pathological condition in which dietary intake fails to meet the body's energetic or nutritional needs. It may be caused by macronutrient or micronutrient deficiencies, high energy expenditure, impaired nutrient absorption or assimilation. Malnutrition can affect all stages of life. In adults, malnutrition is strongly associated with poor clinical outcomes such as increased morbidity, increased mortality and prolonged hospitalization. In children, malnutrition can lead to growth retardation, cognitive impairment and immune dysfunction.
Eligibility
Primary outcome measure(s)
- change of the third lumbar vertebrae skeletal muscle mass and height — baseline, 12 weeks post transplantation
The third lumbar vertebrae skeletal muscle mass represents the sum of the cross-sectional areas of the skeletal muscles at the L3 level, including the psoas major, the erector spinae, the quadratus lumborum, the musculus transversus abdominis, the obliquus externus abdominis and the obliquus internus abdominis. Skeletal muscle mass and height will be combined to report the third lumbar vertebrae skeletal muscle mass index(L3 SMI) in cm\^2/m\^2. - change of weight and height — baseline, 4 weeks, 8 weeks, 12 weeks post transplantation
Weight and height will be combined to report BMI in kg/m\^2.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University | Nanjing | Jiangsu | Recruiting |
More The Second Hospital of Nanjing Medical University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06447220 on ClinicalTrials.gov ↗ ← All trials in China